Search Articles

View query in Help articles search

Search Results (1 to 2 of 2 Results)

Download search results: CSV END BibTex RIS


User Experience of a Computer-Based Decision Aid for Prenatal Trisomy Screening: Mixed Methods Explanatory Study

User Experience of a Computer-Based Decision Aid for Prenatal Trisomy Screening: Mixed Methods Explanatory Study

Therefore, eligible women had to (1) be >16 weeks pregnant or have given birth in the previous year, (2) have made a decision about prenatal screening for trisomy, and (3) be aged at least 18 years. A cutoff of 1 year was chosen to minimize the forgetting bias effect. We excluded women who had participated in previous studies on prenatal screening conducted by our team [19-21].

Titilayo Tatiana Agbadje, Chantale Pilon, Pierre Bérubé, Jean-Claude Forest, François Rousseau, Samira Abbasgholizadeh Rahimi, Yves Giguère, France Légaré

JMIR Pediatr Parent 2022;5(3):e35381

Web-Based Training for Nurses on Using a Decision Aid to Support Shared Decision-making About Prenatal Screening: Parallel Controlled Trial

Web-Based Training for Nurses on Using a Decision Aid to Support Shared Decision-making About Prenatal Screening: Parallel Controlled Trial

In Quebec, prenatal screening for trisomy 21 (Down syndrome) during prenatal follow-up is offered to all pregnant women as part of the state-run health care services, as well as in a few private clinics [1]. Pregnant women face several possible options: whether to take the test, and if so, which one (biochemical test, fetal DNA, or nuchal translucency ultrasound) [2,3].

Alex Poulin Herron, Titilayo Tatiana Agbadje, Sabrina Guay-Bélanger, Gérard Ngueta, Geneviève Roch, François Rousseau, France Légaré

JMIR Nursing 2022;5(1):e31380